ProMetic to Present at BioFinance 2010

MONTREAL, QUEBEC, Apr 06 (MARKET WIRE) --
ProMetic Life Sciences Inc. (TSX: PLI) ("ProMetic") today announced that
Mr. Pierre Laurin, President and Chief Executive Officer, will present at
BioFinance 2010. ProMetic's presentation is scheduled for 10:30 (EDT) on
Wednesday, April 7, 2010, in the Trinity III Room of the Toronto Marriott
Eaton Centre. Details regarding the conference can be obtained at
http://www.biofinance.ca/.

About BioFinance2010

BioFinance 2010 (www.biofinance.ca) is the leading investor conference in
Canada for the life sciences industry. This event brings together key
industry players interested in investment opportunities and issues
affecting companies in the life sciences sector.

About ProMetic Life Sciences Inc.

ProMetic Life Sciences Inc. ("ProMetic") (www.prometic.com) is a
biopharmaceutical company specialized in the research, development,
manufacture and marketing of a variety of commercial applications derived
from its proprietary Mimetic Ligand(TM) technology. This technology is
used in large-scale purification of biologics and the elimination of
pathogens. ProMetic is also active in therapeutic drug development with
the mission to bring to market effective, innovative, lower cost, less
toxic products for the treatment of hematology and cancer. Its drug
discovery platform is focused on replacing complex, expensive proteins
with synthetic "drug-like" protein mimetics. Headquartered in Montreal
(Canada), ProMetic has R&D facilities in the UK, the U.S. and Canada,
manufacturing facilities in the UK and business development activities in
the U.S., Europe, Asia and in the Middle-East.

Contacts:
ProMetic Life Sciences Inc.
Pierre Laurin
President and CEO
514-341-2115
p.laurin@prometic.com

ProMetic Life Sciences Inc.
Anne Leduc
Manager, Investor Relations & Communications
514-341-2115
a.leduc@prometic.com

Copyright 2010, Market Wire, All rights reserved.

-0-